Medicines
From Felipedia
Below are listed some of the common drugs used in feline medicine. See the FDA Green book for a comprehensive list of approved veterinary medicines.
|
Drug (cats) | Indications | Dose | Route | Frequency |
| Acarbose | Diabetes mellitus | 12.5 - 20 mg | Oral | with each meal |
| Acemannan (Aloe vera derivative) | Immunomodulation | 1-2 mg/kg | Intralesional, IP or SQ | weekly |
| Acepromazine (ACP) | Sedation, restraint | 0.05-2.25 mg/kg | SQ, IM, PO | q 8-12hrs |
| Aortic thromboembolism | 0.15-0.3 mg/kg | SQ | q 8-12hrs | |
| Amphetamine toxicosis | 0.05 -1.0 mg/kg | IV, IM, SQ | q 8-12hrs | |
| Acetazolamide | Glaucoma | 5-10 mg/kg | PO | q 8-12hrs |
| Acetylcysteine | Mucolytic and acetaminophen toxicity | 140 mg/kg | IV | loading dose |
| 70 mg/kg | PO | 4-6 x 5-7 treatments | ||
| Acetylsalicylic acid | Antipyretic | 6-10 mg/kg | PO | q 48 - 72hrs |
| Antithrombotic | 80 mg/cat or 25 mg/kg | PO | 2 times/wk | |
| Anti-inflammatory | 10-20 mg/kg | PO | q 48 hrs | |
| Analgesia | 10 mg/kg | PO | q 48hrs | |
| Actinomycin-D | Anticancer / antimicrobial | 0.5-0.9 mg/m2 | IV | once every 3 weeks |
| Acyclovir | Anti-herpes viral | 200 mg | PO | q 6hrs |
| S-Adenosylmethionine (SAME) | Replenishes glutathione stores in chronic liver disease | 20-30 mg/kg | PO | q 24hrs |
| Alizin | Antiprogestin, induction of parturition, abortifacient (for mesalliance) | 10mg/kg | SQ | Days 1, 2, 7 & 14 |
| Albendazole | Lungworm | 50 mg/kg | PO | daily for 21 days |
| Albuterol (Salbutamol) | Bronchodilation | PO | q 6 - 8hrs | |
| Allopurinol | Urate urolithiasis | 10 mg/kg | PO | q 8 - 12hrs for 30 days |
| Alprazolam (Benzodiazepine) | Elimination behavioural problems | 0.125-0.25 mg/cat | PO | q 12hrs |
| Aluminium carbonate gel | Phosphate binder | 10-30 mg/kg | PO with meals | q 8hrs |
| Aluminium hydroxide | Antacid | 20-30 ml | PO | q 2 - 4hrs |
| Phosphate binder | 30-90 mg/kg | PO with meals | q 8 - 24hrs | |
| Amantadine | Analgesia for chronic pain | 3-5 mg/kg | PO | daily for 7-14 days |
| Amikacin | Susceptible infections | 15-22 mg/kg | IM, IV, SQ | q 24hrs |
| Aminopentamide (Centrine) | Antidiarrheal | 0.1 mg/cat | SC, IM, PO | q 8 - 12hrs |
| Aminophylline | Bronchodilator | 4-6.6 mg/kg | PO | q 8 - 12hrs; use with caution in cats |
| 2-5 mg/kg | IV infusion | q 12hrs | ||
| Aminopromazine | Smooth muscle relaxant | 2.0-4.5 mg/kg | PO | q 12hrs |
| 6-aminosalicylic acid | Irritable bowel syndrome | see mesalamine, olsalazine | ||
| Amitriptyline (Endep-10) | Behaviour, urine spraying | 2 mg/kg or 5-10 mg/cat | PO | q 24hrs |
| Amlodipine besylate (Norvasc) | Systemic hypertension | 0.625 mg/cat | PO | q 24hrs |
| Ammonium chloride | Struvite dissolution | 800 mg/cat | PO | q 24hrs |
| Amoxicillin/clavulanic acid | Susceptible infections | 10-20 mg/kg | PO | q 12hrs |
| Amoxil (Amoxicillin) | Susceptible infections | 4-11 mg/kg | PO | q 12hrs |
| Amphetamine sulphate | CNS stimulation during certain toxicoses | 5 mg/cat | PO | q 12hrs |
| Amphotericin B | Systemic mycoses | 0.15-1 mg/kg in 5% dextrose | IV | q 48hrs to a total cumulative dose of 10mg/kg |
| SQ | diluted 1:10 in saline | |||
| Ampicillin | Susceptible infections | 20-60 mg/kg | PO | q 8 - 12hrs |
| Amprolium | Coccidiosis | 60-100 mg/kg | PO | q 24hrs x 5 d |
| With sulfadimethoxine | 150 mg/kg | PO | q 24hrs x 5d | |
| Aprotonin | Protease inhibitor (Pancreatitis), fibrinolytic agent | 5000 KUI (kallikrein inhibitor units)/kg | IP | q 6 - 8hrs |
| Ascorbic acid (Vitamin C) | Feline infectious peritonitis | 25-125 mg/kg/day | PO | q 24hrs |
| Acetaminophen toxicosis | 30 mg/kg | PO, SQ | 6x7 treatments | |
| Asparaginase | Lymphosarcoma | 10,000 U/m2 | IV | weekly as part of a protocol |
| Aspirin | Antipyretic | 6-10 mg/kg | PO | q 48 - 72hrs |
| Atenolol (Tenormin) | ß1-blocker for Hypertrophic cardiomyopathy + Hypertension | 6.25 mg/cat | PO | q 24hrs |
| Atipamezole (Antisedan) | Medetomidine reversal | equivolume | IM | as needed |
| Atovaquone | Antiprotozoal (pneumocystosis) | 13.3 mg/kg with fatty meal | PO | q 8hrs x 21 days |
| Atracurium besylate | Paralytic anaesthetic agent | 0.1-0.25 mg/kg | IV | repeated q 30mins |
| Atropine | Sinus bradycardia | 0.02-0.04 mg/kg | IM, IV, SQ | as required |
| Organophosphate toxicity | 0.2-2.0 mg/kg | IM, SQ | q 2hrs | |
| Aurothioglucose | Pemphigus, Gingivitis and podomatitis | 2 mg | IM | stat, then 1 mg/kg weekly |
| Azathioprine | Enteritis | 0.2-0.3 mg/kg | PO | q 24-48hrs |
| Immune-mediated haemolytic anaemia | 1 mg/kg | PO | q 24-48hrs | |
| Immunosuppression | 1.1 mg/kg | PO | q 48hrs | |
| Azithromycin (Zithromax)] | Susceptible infections | 5 mg/kg | PO | q 24 - 48hrs |
| Susceptible infections | 80 mg stat | PO | weekly x 3 | |
| Aztreonam | Susceptible infections | 12-25 mg/kg | IV, IM | q 8-12hrs |
| Baquiloprim | coccidiosis | 30 mg/kg | PO | q 48hrs x 2 |
| Baytril | Susceptible infections | 5.0-20.0 mg/kg | PO, SQ, IM, IV (with caution - may cause blindness) | q 24hrsfor 7-10 days |
| Beclomethasone dipropionate | Anti-inflammatory | 200 mg | Inhalant | as required |
| Benazepril in cats (Fortekor) | Afterload reduction (Renal, CHF) | 0.25-0.5 mg/kg | PO | q 24hrs |
| Benzimidazole | Trypanosomiasis | 5 mg/kg | PO | q 24hrs for 4 months |
| Benzocaine | Local anaesthetic | 1-5 ml | SQ | as required |
| Benzoyl peroxide | Seborrheic, antibacterial | leave on skin for 10mins | q 3 - 4days for 2 weeks | |
| Betamethasone | Anti-inflammatory | 0.1-0.2 mg/kg | PO | q 12 - 24hrs |
| Bethanechol | Bladder atony, dysautonia, FLUTD | 1.25-5.0 mg | PO | q 8- 12hrs |
| Bisacodyl | Stool softener | 2-5 mg/cat | PO | q 24hrs as needed |
| Bismuth subcarbonate | GI tract protectant | 0.3-3.0 gm | PO | q 4hrs |
| Antidiarrheal, antiemetic | 1-3 ml/kg | PO | q 4 - 6hrs | |
| Bleomycin | Chemotherapy | 10 µg/m2 | IV, SQ | q 24hrs for 4 days, then weekly; max dose 200mg/m2 |
| Bran | Stool softener | 1-2 teaspoons/400g food | PO | as needed |
| Brewer's yeast | B vitamin source | 0.2 µg | PO | q 24hrs |
| Bromide, Potassium | Anticonvulsant | 30-60 mg/kg | PO | q 12hrs |
| Bromocriptine mesylate | Cushing's syndrome, false pregnancy, lactation cessation | 10-30 µg/kg | PO | q 24hrs for 10 -16 days |
| Bunamidine | Parasites - Taenia spp, Dipylidium spp | 20-50 mg/kg | PO | after 3hr fast |
| Bupivicaine hydrochloride | Local Anaesthetic | 0.22-3.0 ml/cat | Epidural | stat |
| Buprenorphine | Opioid analgesic | 0.005-0.01 mg/kg | IV, IM | q 4-8hrs |
| Buspirone (Clomicalm) | Behavioural therapy | 2.5-5.0mh/cat | PO | q12-24hrs |
| Busulfan | Chronic myelocytic leukaemia | 3-4mg/m2 or 0.1 mg/kg | PO | q 24hrs |
| Butamisole | Intestinal parasites - Hookworm, whipworm | 2.2mg/kg | SQ | q 21days |
| Butorphanol | Preanaesthetic | 0.05-0.4mg/kg with ACP | IV, IM, SQ | |
| Antiemetic | 0.2-0.6mg/kg | SQ, IM, IV | ||
| Analgesia | 0.1-0.8 mg/kg | PO | q 6 - 12hrs | |
| Calcitriol | Hypoparathyroidism, Hyperparathyroidism (primary), Renal secondary hyperparathyroidism | 1.5 - 3.0 ng/kg | PO | q 24hrs |
| Calcium carbonate | Nutritional supplement | 1/2 tsp | PO | daily |
| Phosphate binder | 60-100 mg/kg | PO | daily | |
| Calcium chloride 10% | Ventricular asystole | 1 ml/9kg or 0.1-0.3ml/kg | IV (slowly) | stat |
| Hypocalcaemia | 1 ml/9kg | IV | stat | |
| Calcium citrate | Calcium replacement, Feline lower urinary tract disease (FLUTD) | 10-30 mg/kg | PO | q 8hrs |
| Calcium EDTA | Lead poisoning | 100 mg/kg/day | SQ | daily for 5 days |
| Calcium gluconate | Ventricular asystole | 0.5-1.5 ml/kg | IV (slowly) | as required |
| Hypocalcaemia, hyperkalemia | 0.5-1.5 ml/kg | IV (slowly) | as required | |
| Captan powder 50% | Fungal infections | 2 tablespoons/gal water | topically, do not rinse | 2-3 x week |
| Captopril | Vasodilator | 2-3 mg/cat | PO | q 8-12hrs |
| 3-6.25 mg/cat | PO | q 12hrs | ||
| Carbenicillin | Susceptible infections | 15-30 mg/kg | IV | q 8hrs |
| Carbenicillin indanyl sodium | Urinary tract infections | 10-55 mg/kg | PO | q 8hrs |
| Carbimazole | Hyperthyroidism | 5 mg/cat | PO | q 8 - 12hrs |
| Carboplatin | Chemotherapy | 200 mg/m2 | IV | q 4weeks |
| Carmustine | Chemotherapy | 50 mg/m2 | IV | q 6weeks |
| Carprofen (Rimadyl) | Analgesic | 1-4 mg/kg | SQ | stat |
| 0.5-1.0 mg/kg | PO | q 24hrs | ||
| Cefadroxil (Cefa-drops - cephalosporin) | Susceptible infections | 50 mg/cat | PO | q 24hrs for 1-4 weeks |
| Cephalexin (Rilexin) | Susceptible infections | 10-35 mg/kg | PO | q 8 - 12hrs |
| Anti-emetic | 1.0 mg/kg | SQ/PO | q 24 hrs for 4 days, then rest 2 days | |
| Cetacaine | Topical anaesthetic | Use cautiously | Topical | May cause methaemaglobinaemia |
| Charcoal, activated | Adsorbent for poisonings | 1-8g/kg | PO | as needed |
| Chlorambucil | Chemotherapy | 0.1-0.5mg/kg | PO | q 48-72hrs |
| Immune mediated skin diseases (Pemphigus, EGC) | 0.1-0.2mg/kg | PO | q 48hrs with prednisolone | |
| Chloramphenicol | Susceptible infections | 50mg/cat | PO | q 12hrs |
| Chlordiazepoxide-clidinium (Benzodiazepine) | Irritable bowel syndrome | 1-2 tabs | PO | q 12hrs |
| Chlorhexidine 0.5% | Burns | dilute 1:40 with saline | topically | q 24hrs |
| Chlorothiazide | Diuretic | 10-40 mg/kg | PO | q12hrs |
| Partial ADH deficiency | 20-40 mg/kg | PO | q12hrs | |
| Chlorpheniramine | Antihistamine | 1-2 mg/cat | PO | q 8-12hrs |
| Excessive grooming | 2-4 mg/cat | PO | q 12-24hrs | |
| Antiemetic | 0.5 mg/kg | IM | q 6-8hrs | |
| Chlortetracycline hydrochloride | Susceptible infections | 25 mg/kg | PO | q 6-8hrs |
| Cholecalciferol (Vit D) | Hyperparathyroidism (primary) Hypocalcaemia | 500-2000 U/kg | PO | q 24hrs |
| Cimetidine | Oesophagitis, gastric ulceration, antiemetic, chronic gastritis | 5-15 mg/kg | PO, IV, IM | q 8 -12hrs |
| Immunomodulator | 10-25 mg/kg | IV, IM, PO | q 12hrs | |
| Ciprofloxacin | not bioavailable in cats | |||
| Cisapride (Prepulsid) | constipation, megacolon | 0.5-5.0mg/cat | PO | q 12hrs |
| Clarithromycin | Mycobacterium spp | 50 mg/cat | PO | q 12hrs |
| Clavulox (Amoxicillin / Clavulanic acid) | Susceptible infections | 10-20 mg/kg | PO | q 12hrs |
| Clindamycin | Anaerobic infections | 5-11 mg/kg | PO | q 12hrs |
| Stomatitis, Pancreatitis | 22 mg/kg | PO | q 24hrs | |
| Exocrine pancreatic insufficiency | 5-10 mg/kg | PO | q 6 - 8hrs | |
| Enteroepithelial cycle | 12.5-50 mg/kg | PO | q 12hrs | |
| Clofazimine | Mycobacterium spp | 4-8 mg/kg | PO | q 24hrs for 6 weeks |
| 50 ng/cat | PO | q 48hrs | ||
| Clomipramine | Behaviour modification | 1-5 mg/cat | PO | q 12 - 24hrs |
| Clonazepam (Benzodiazepine) | Anticonvulsant, behaviour therapy | 0.5 mg/kg | PO | q 8-12hrs |
| Clorazepate (Benzodiazepine) | Anxiolytic drug | 1-2 mg/kg | PO | q 8 - 12hrs |
| Clotrimazole | Fungal infections | apply to lesion | topical | q 12hrs |
| Fungal infections | 60 ml of 1 g/dl of polyethylene glycol intranasal | over 1 hr under general anaesthesia | ||
| Cloxacillin | Susceptible infections | 20-40 mg/kg | PO, IM, IV | q 4 - 8hrs |
| Coal tar shampoos | Seborrhoea | Keep in contact with skin for 10 mins | Topically | q 24hrs |
| Cobalamin | see Vit B12 | |||
| Cod liver oil | 1 teaspoon / 10 kg | |||
| Codeine | Pain relief | 0.5-4 mg/kg | PO | q 6 - 12hrs |
| Antitussive, analgesia | 0.1-0.3 mg/kg | PO | q 4 - 6hrs | |
| Colchicine | Antifibrotic | 0.01-0.3 mg/kg | PO | q 4 - 6hrs |
| Colony stimulating factor | Neutropenia | 2.5-5.0 mg/kg | SQ | q 24hrs |
| Corticotrophin gel (ACTH) | Response test | pre-ACTH sample 0.5-2.2 IU/kg | IM | |
| Cortisone acetate | Hypoadrenocorticism ( Addison's disease) | 1 mg/kg | PO, IM | q 24hrs |
| Cosequin® | Osteoarthritis | 1 capsule | PO | q 24hrs |
| Cosyntropin | pre-ACTH sample | 0.125 mg/cat | IV | |
| 1-2 mg/kg | PO (with caution) | q 12hrs x 2 | ||
| Cromolyn sodium 4% (Cromone) | Allergic conjunctivitis | Topically | q 4 - 6hrs | |
| Cyanocobalamin | Vit B12 deficiency | 50-1000 µg | PO, IM, SQ | q 24hrs |
| Cyclizine | Antiemetic | 4 mg/kg | IM | q 8hrs |
| Cyclophosphamide | Chemotherapy | 100 mg/m2 | IV | |
| Mammary tumours | 100 mg/m2 | PO | q 3 weeks with doxorubicin | |
| Immune-mediated haemolytic anaemia | 2 mg/kg (50mg/m2) | PO | q 24hrs for 4 days per week | |
| Lymphosarcoma, myeloproliferative disorders | 50 mg/m2 | PO | q 48hrs | |
| Autoimmune skin diseases | 50 mg/m2 | PO | q 24hrs 4 days/wk or q 48hrs | |
| Multiple myeloma | 7 mg/kg | PO | once | |
| FIP | 2-4 mg/kg | PO | q 24hrs 4 days a week | |
| Iritable bowel disease | 6.6 mg/kg | PO | q 3days then q 24hrs | |
| 2.2 mg/kg | PO | q 24hrs | ||
| Immunosuppressive therapy | 2.2 mg/kg (6.25-12.5 mg/cat) | PO | q 48hrs or q 24hrs for 4 days a week | |
| Cyclosporin | Thrombocytopenia, SLE, sebaceous adenitis | 4-6 mg/kg | 4hr IV infusion | q 24hrs (avoid extravasation) |
| 3-7 mg/kg | PO | q 12hrs | ||
| 10 mg/kg | PO | q 12hrs | ||
| Cyclosporine ophthalmic | Dry eye, Eosinophilic keratitis | 1-2% solution | drop in eye | q 12hrs |
| Cyclothiazide | Diuretic | 0.5-1.0 mg/kg | PO | q 24hrs |
| Cyproheptadine | Appetite stimulant, aortic thromboembolism | 1-4 mg/cat | PO | q 12 - 24hrs |
| Cytarabine | Chemotherapy | 30-50 mg/kg | IV, IM, SQ | once a week |
| 100 mg/m2 | IV. IM, SQ | q 24hrs for 4 days then | ||
| 20 mg/m2 | Intrathecal | q 24hrs for 1 - 5 days | ||
| Cythioate | Tick prevention | 1.5-3.3 mg/kg | PO (tab) | q 72hrs or 2 x week |
| 0.22 ml/kg | PO (liquid) | q 72hrs or 2 x week | ||
| Dacarbazine | Lymphoreticular neoplasms | 200-250 mg/m2 | IV | q 24hrs for 5 days, every 21 days |
| Soft tissue sarcomas | 1000 mg/m2 | IV infusion | over 6 - 8hrs, every 21 days | |
| Dactinomycin (Actinomycin-D) | Chemotherapy | 0.015 mg/kg | IV | q 24hrs for 3 - 5 days, wait 3 weeks then |
| 0.7-1.5 mg/m2 | IV | weekly | ||
| Dalteparin (low MW heparin) | DIC, Thrombosis | 70 IU/kg | SQ | q 24hrs |
| Danazolol | Immune-mediated disorders | 5-10 mg/kg | PO | q 12hrs |
| Dapsone | Mycobacterial infections | 1.1 mg/kg | PO | q 12hrs for 4-6 weeks |
| Brown recluse spider bite | 0.7-1.0 mg/kg | PO | q 8hrs | |
| Decatibine (Dacogen) | Chemotherapy. Feline leukemia, methylation inhibitor | 400-800 mg/m2 | IV, SQ | q 24hrs x 10 |
| Deferoxamine mesylate | Iron chelator | 10 mg/kg | IV, IM, SQ | q 2hrs for 2 doses then q 8hrs for 24 hrs |
| Repertusion (ischaemia) injuries | 50 mg/kg | IV | over 5 mins | |
| Demeclocycline | Inappropriate ADH secretion | 3-12 mg/kg | PO | q 6 - 12 hrs |
| Deprenyl (Fitergol) | Hyperadrenocorticism, Cognitive disorders | see Selegiline | ||
| Derm caps | Skin disorders | 1 capsule per 9kg | PO | q 24hrs |
| Desmopressin acetate | Central diabetes insipidus | 0.3 µg/kg | IM | q 12 - 24hrs |
| Desoxycorticosterone acetate | Hypoadrenocorticism | 0.2-0.4 mg/kg | conjunctivally | q 24hrs, max 5mg |
| Desoxycorticosterone pivalate | Addison's disease | 25 mg | IM | stat |
| Dexamethasone | Central oedema, spinal cord trauma, DJD, other CNS trauma | 2 mg/kg | IV | then, |
| 1 mg/kg | IV, SQ | q 8-12hrs, then | ||
| 0.1 mg/kg | IV, SQ, PO | q 8-12hrs | ||
| Hydrocephalus | 0.25 mg/kg | IV, IM, PO | q 6 - 8hrs | |
| Shock, anaphylaxis | 4 - 6 mg/kg | IV (slowly) | ||
| Immune-mediated disease | 0.25-1.25 mg/kg | PO | q 12 - 24hrs | |
| 0.1-0.15 mg/kg | SQ, PO | q 12hrs for 5 - 7 days, then taper dose | ||
| Addison's disease | 0.1-0.5 mg/kg | SQ, IV | with mineralocorticoids | |
| Asthma | 1 mg/kg | IV | then | |
| 0.25-1.0 mg/cat | PO | q 8 - 24hrs | ||
| Dexrazoxane | Iron chelation for doxorubicin-induced cardiotoxicity | 25 mg/kg (ratio of 10-20:1 dexrazoxane : doxorubicin) | IV | 15 mins before doxorubicin |
| Dextran 40 | Shock | 10-20 ml/kg | IV | q 24hrs |
| Dextran 70 | Volume expander | 10-20 ml/kg | IV | q 24hrs to effect |
| Dextroamfetamine | Narcolepsy | 5-10 mg | PO | q 8hrs with imipramine |
| Hyperkinesis | 0.2-1.3 mg/kg | PO | as needed | |
| Dextromethorphan | Coughing | 0.5-2.0 mg/kg | PO, SQ, IV | q 6 - 8 hrs |
| Dextrose, 50% | Hypoglycaemia, insulin overdose | 2 ml/kg | PO | |
| 0.25-1.00 ml/kg | IV | |||
| Dextrose, 5% | Hypoglycaemia, insulin overdose | 40-50 ml/kg | IV, SQ, IP | as needed |
| Diazepam (Valium) | Sedation | 0.5-2.2 mg/kg | PO | as needed |
| Seizures | 0.15-0.70 mg/kg or 2-5mg/cat | PO, IV | q 8hrs | |
| Status epilepticus, certain toxicoses | 0.5-1.0 mg/kg | IV | in increments of 5 - 20mg | |
| Strychnine-induced seizures | 2-5 mg/kg | IV | as needed | |
| 0.5 mg/kg | IV | |||
| Reflex dyssynergia (urethral obstruction) | 2.5-5.0 mg/cat | PO | q 6 - 8hrs | |
| 0.5 mg/kg | IV | |||
| Urinary disorder in cat | 1.25-2.5 mg/cat | PO | q 8 - 12hrs | |
| Appetite stimulant | 0.05-0.4 mg/kg | IV, PO, IM | q 24 - 48hrs | |
| 1 mg/cat | PO | q 24hrs | ||
| Overgrooming | 1-2 mg | PO | q 12hrs | |
| 1 mg/kg | PO | q 8 - 12hrs | ||
| Dichlorphenamide | Glaucoma | 3-5 mg/kg | PO | q 8- 12hrs |
| Dichlorvos | Parasites - Hookworm, whipworm, roundworm | 11-22 mg/kg | PO | repeat in 3 weeks |
| Dicloxacillin | Susceptible infections | 10-50 mg/kg | PO | q 6 - 8hrs |
| Dicoumarol | Anticoagulant | 5 mg/kg | PO | load, then |
| 1.3-2.6 mg/kg | PO | oid (monitor response) | ||
| Dicyclomine | Detrusor hyperspasticity or urge incontinence | 10 mg/cat | PO | q 6 - 8hrs |
| Diethylcarbamazine | Heartowrm prophylaxis | 6.6 mg/kg | PO | q 24hrs |
| Diethylstilboestrol | Feline symmetrical alopecia | 0.05-0.1 mg/cat | PO | q 24hrs |
| Difloxacin (Fluoroquinolone) | Susceptible infections | 5-10 mg/kg | PO | q 24hrs |
| Digoxin | Congestive heart failure | 0.005-0.008 mg/kg/day | PO | divided in 12hr doses |
| Dihydrostreptomycin | Susceptible infections | 10-30 mg/kg | IM, SQ | q 12 - 24hrs |
| Dihydrotachysterol | Milk fever | 0.03-0.06 mg/kg | PO | q 24hrs for 3, then |
| 0.01-0.02 mg/kg | PO | q 24hrs | ||
| Diltiazem | Hypertension, Hypertrophic cardiomyopathy, Supraventricular tachycardia | 0.125-0.35 mg/kg | IV | |
| 0.5-2.5 mg/kg | PO | q8hrs | ||
| Dimenhydrinate | Antihistamine | 12.5 mg/cat | PO, IM, IV | |
| Dimercaprol (BAL) | Arsenic toxicosis | 2.5-5.0 mg/kg | IM | q 4hrs for 2 days, then q 8hrs for 3 days, then q 12hrs for 10 days |
| Dimethylsulfoxide (DMSO) | Spinal cord trauma, Amyloidosis | 0.5-1 g/kg | IV (10%) | q 6 - 8hrs over 45 min |
| Diminazine aceturate | Feline babesiosis, Trypanosomiasis | 2.0-3.5 mg/kg | IM | Once |
| 3.5 mg/kg | IM, SQ | q 24hrs for 2 days | ||
| Dinoprost | see prostaglandin F2a | |||
| Diphenhydramine (Benadryl) | Antihistamine | 2-4 mg/kg | PO | q 6 - 8hrs |
| Mast cell tumour, antiemetic | 2 mg/kg | IM, IV | q 12hrs as needed | |
| Anaphylaxis, urticaria, angioneurotic oedema | 2 mg/kg | IM, IV | q 12hrs as needed | |
| Diphenoxylate HCl | Acute colitis | 0.05-0.1 mg/kg | PO | q 12hrs |
| 0.6-1.2 mg/cat | PO | q 8 - 12hrs | ||
| Diphenylthiocarbazone | Thallium toxicosis | 50-70 mg/kg | PO | q 8hrs |
| Diphemanil methylsulphate | Anticholinergic (bronchodilator) | 1.8 mg/kg | IM | q 12hrs |
| Dipyridamole | Antithrombotic | 4-10 mg/kg | PO | q 24hrs |
| 25 mg/kg | q 8hrs (low dose);12 - 24hrs (high dose) | |||
| Disodium EDTA | Calcium keratopathy | 0.37% solution | topically | lavage cornea for 15 - 20 mins |
| 1% solution; 1-2 drops | topically | q 12 hrs for several weeks | ||
| Dithiazanine iodide | Microfilaricide | 6.6-11 mg/kg | PO | q 24 hrs for 7 - 10 days |
| DL methionine | see methionine | |||
| Dobutamine | Positive ionotrope | 0.5-2.0 µg/kg/min | IV infusion (caution) | 1 min |
| Docusate sodium or calcium | Stool softener | 50 mg/cat | PO | q 12 - 24hrs |
| disposable enema | 250 mg/12ml glycerin | Rectal | q 24hrs as needed | |
| Dolasetron | Antiemetic | 0.6 mg/kg | PO, IV, SQ | q 24hrs |
| Dopamine HCl | Inotropic agent | 2-25 µg/kg (up to 50 µg/kg if severe hypotension or shock) | IV infusion | 1 min |
| Renal vasodilator, acute renal failure | 2-5 µg/kg (low dose) | IV infusion in 5% dextrose/saline | 1 min | |
| Doxapram | Respiratory stimulant in neonates | 1-5 mg/kg | IV (umbilical vein) | as needed |
| 1-2 drops | PO | as needed | ||
| Doxorubicin Adriamycin) | Chemotherapy | 10-30 mg/m2 | IV | q 21 days |
| Doxycycline HCl (Vibravet) | Susceptible infections | 5-10 mg/kg | PO, IV | q 12 - 24hrs |
| Doxylamine succinate | Antihistamine | 1.1-2.2 mg/kg | PO, SQ, IM | q 8 - 12hrs |
| Edrophonium | Myasthenia gravis diagnosis | 2.5 mg/cat | IV | stat |
| Emetine | Vomiting | 3.3 ml/kg, dilute 50:50 with water | PO | stat |
| Enalapril (ACE inhibitor) | Hypertension, Congestive heart failure, Valvular endocardiosis | 0.25-0.5 mg/kg | PO | q 12 - 24hrs |
| Endotoxin antisera | Endotoxemia | 408 mg/kg | IV | stat |
| Enflurane | Gaseous anaesthesia |
Induction: 2-3% Maintenance: 1.5-3.0% | intratracheal | as needed |
| Enilconazole 10% | Nasal aspergillosis | 5% solution (1:1 in water) | topically | q 12hrs for 7 - 10 days |
| 10-20 mg/kg (10% solution: 50:50 in water | instil into nasal sinus | q 12hrs for 10 - 14 days | ||
| Dermatophytes | dilute to 0.2% solution | wash | q 72 - 96hrs for 4 treatments | |
| Enrofloxacin | Susceptible infections | 5.0-20.0 mg/kg | PO, SQ, IM, IV (with caution - may cause blindness) | q 24hrs for 7 - 10 days |
| Ephedrine | Bronchodilator, urinary incontinence | 2.0-5.0 mg/kg | PO | q 8 - 12hrs |
| Epinephrine: Use 1:10,000 stock, dilute 1:1000 in 10ml saline | Cardiac arrest | 0.2 ml/kg | IV, intratracheal | q 5 - 15 min as needed |
| Anaphylaxis, Feline asthma | 0.1 ml/kg | SQ, IM, IV | q 5 - 15 min as needed | |
| Epsiprantel | Parasites - Dipylidium spp, Taenia spp | 2.5-2.75 mg/kg | PO | stat |
| Ergocalciferol | Vitamin D | 500-2000 IU/kg | PO | q 24hrs |
| Erythromycin | Susceptible infections | 10-22 mg/kg | PO, IV | q 8hrs |
| Erythropoietin (Eprex 1000) | Anaemia from Kidney disease | 50-100 IU/kg | SQ | 3 x weekly for 12 weeks then twice weekly (as need to maintain PCV at 35%) |
| 400 IU/kg | IV, SQ | once a week | ||
| Esmolol | Selective B1 blockade | 0.05 mg/kg | slow IV | loading dose, then |
| 50-200 µg/kg | IV infusion | per min | ||
| Estradiol cypionate | mesalliance | 125-250 µg/cat | IM | between 40hrs and 5 days post-coitus |
| Ethacrynic acid | Diuretic, pulmonary oedema | 0.2-0.4 mg/kg | IV, IM | q 4 - 12hrs |
| Ethanol (20%) | ethylene glycol toxicosis | 5 ml/kg | IV | q 6hrs for 30hrs, then q 8hrs for 32 hrs |
| Ethosuximide | Epilepsy | 40 mg/kg | PO | load, then |
| 20 mg/kg | PO | |||
| Etidronate disodium | Hypercalcemia | 10 mg/kg | PO | q 2hrs |
| Etomidate | Anaesthetic induction | 0.5-3.0 mg/kg | IV | as needed |
| With opioids | 0.5-1.0 mg/kg | IV | as needed | |
| Etretinate | Dermatopathy | 1-2 mg/kg | PO | q 24hrs |
| Euthanasia solution | Pentobarbitone sodium | 120 mg/kg for first 4.5kg; 60mg/kg thereafter | IV | stat |
| with phenytoin | 1 ml / 4.5 kg | IV | stat | |
| Famotidine | Gastric antisecretory (H2 receptor antagonist) | 0.5 mg/kg | IM, SQ, PO | q 12 - 24hrs |
| Famciclovir | Antiviral | 62.5 mg/kg | PO | q 12 - 24hrs |
| Fatty acids (essential) | Atopy, fatty acid deficiency | Derm caps - 1 cap/cat | PO | q 24hrs |
| Febantel | Antiparasiticide | 10 mg/kg per 1mg/kg praziquantel | PO | q 24hrs for 3 days |
| Fenbendazole | Capillaria plica, Coccidiosis | 25-50 mg/kg | PO | q 12hrs for 3-14 days |
| Mesocestoides spp | 50-100 mg/kg | PO | q 12 - 24hrs for 28 days, repeat in 1 week | |
| Fentanyl citrate (Patches) | Analgesia | 0.01 mg/kg | IV, SQ, IM | |
| transdermal | q 72 - 96hrs | |||
| Ferric cyanoferrate | Thallium toxicosis | 4-8 mg/kg | PO | q 8hrs |
| Ferrous sulphate | Anaemia | 50-100 mg/cat | PO | q 24hrs |
| Fitergol ( Deprenyl) | Cushing's syndrome, Cognitive disorders | see Selegiline | ||
| Flavoxate | Urinary urge incontinence (Detrusor hyperspasticity) | 100-200 mg/cat | PO | q 6 - 8hrs |
| Florfenicol (Chloramphenicol analogue) | Susceptible infections | 22-50 mg/kg | PO, IM, SC | q 12hrs |
| Fluconazole | Fungistatic / fungicidal (dose related) | 2.5-10.0 mg/kg | PO with food | q 12 - 24hrs |
| Cryptococcus | 50-100 mg/cat | PO with food | q 12 - 24hrs | |
| Flucytosine | Cryptococcus | 30-50 mg/kg | PO | q 6 - 8hrs |
| Urinary candidiasis | 67 mg/kg | PO | q 8hrs | |
| Fludrocortisone acetate (Aldosterone analogue) | Addison's disease | 0.1-0.2 mg/cat | PO | q 24hrs |
| Flumazenil | Hepatic encephalopathy | 0.2 mg/cat | IV | as needed |
| Flumethasone | Anti-inflammatory | 0.15-0.3 mg/kg | IV, IM, SQ | q 24hrs |
| Flunixin meglamine | Anti-inflammatory | 0.5-2.2 mg/kg | IV, IM, SQ | stat |
| Fluoxetine (Prozac) | Behavioural problems (SSRI) | 0.5-4 mg/cat | PO | q 24hrs |
| Flurazepam (Benzodiazepine analogue) | Appetite stimulant | 0.2-0.4 mg/kg | PO | q 4 - 7 days |
| Flurbiprofen (an NSAID - 0.03% solution) | Allergic conjunctivitis | 0.2-0.4 mg/kg | Topically | q 8 - 12hrs |
| Folic acid | Dietary supplement | 2.5 mg/cat | PO | q 24hrs |
| Folinic acid | 'Rescue' for sulfonamides | 1 mg/kg | PO | q 24hrs |
| Follicle stimulating hormone (FSH) | Induction of oestrus | 500 IU HCG | IV, IM, SQ | q 24hrs for 2 days |
| Fomepizole (4-Methylpyrazole) | Antifreeze toxicity | 20mg/kg | IV | stat |
| 15mg/kg | IV | q12hrs for 2 days, then | ||
| 5mg/kg | IV | as required | ||
| Foscanart sodium (phosphonoformate) | Susceptible viral infections | 13.3 mg/kg | IV, PO | q 8hrs |
| Furazolidone | Giardia spp | 4 mg/kg | PO | q 12hrs for 7-10 days |
| Amoebic colitis | 2.2 mg/kg | PO | q 8hrs for 7-10 days | |
| Coccidiosis | 8-20 mg/kg | PO | q 24hrs for 5 days | |
| Furosemide | Diuresis | 2-4 mg/kg | IV, IM, PO | q 8 - 12hrs as needed |
| Hypertension | 0.5-2.0 mg/kg | PO | q 12hrs | |
| Hydrocephalus, brain oedema | 1-2 mg/kg | PO | q 12hrs | |
| Gabapentin | Epilepsy (add-on) | 10 mg/kg | PO | q 8 - 12hrs |
| Gamma globulin | Immune-mediated disease | 1 g/cat | IV | q 6 - 12hrs |
| Gentamicin | Susceptible infections | 6-8 mg/kg | IM, SQ, IV | q 24hrs |
| Glimipiride (sulfonylurea) | Non-insulin-dependant diabetes mellitus | 1-2 mg/cat | PO | q 24hrs |
| Glipizide (sulfonylurea) | Non-insulin-dependant diabetes mellitus | 0.25-0.5 mg/kg | PO | q 8 - 12hrs |
| 2.75-7.5 mg/cat | PO | q 8 - 12 hrs (gradual increase in maximum dose as needed based on serum glucose) | ||
| Glyburide (sulfonylurea) | Non-insulin-dependant diabetes mellitus | 0.2 mg/kg | PO | q 24hrs |
| 0.625 mg/cat | PO | q 24hrs | ||
| Glycerin | Acute glaucoma | 1-2 ml/kg of 50% solution | PO | repeated once at 8 hrs |
| Glyceryl guaiacolate | Muscle relaxation during certain toxicoses | 110 mg/kg | IV | as needed |
| Glyceryl monoacetate | Sodium fluoroacetate toxicosis | 0.55 mg/kg hourly to 2-4mg/kg | IM | as needed |
| Glycopyrrolate | Sinus bradycardia, SA block, AV block | 0.005-0.010 mg/kg | IV, IM | as needed |
| Hypersialism | 0.01 mg/kg | SQ | as needed | |
| Preanaesthetic | 0.01-0.02 mg/kg | SC, IM | stat | |
| Gold sodium thiomalate | Immune-mediated disease | 1-5 mg/cat | IM | weekly x 3; 2nd + 3rd week at 2 - 10 mg/cat |
| Gonadotrophin releasing hormone (GnRH) | Cystic ovarian syndrome | 50-100 µg/cat | IM | for 1-3 treatments |
| 25 µg/cat | IM | after mating, or on days 2 of oestrus | ||
| Granulocyte colony stimulating factor | Neutropenia | 3-10 μg /kg | SQ | q 12 - 24hrs |
| Griseofulvin (Grisovin) | Antifungal | 10-30 mg/kg | PO | q 24hrs for 4 weeks |
| Guaifenesin | Tranquiliser | 44-88 mg/kg (alone) | IV | stat |
| 33-88 mg/kg (with thiamylal) | IV | stat | ||
| 33-88 mg/kg (with ketamine) | IV | stat | ||
| Haloperidol | Psychogenic alopecia | 2 mg/cat | PO | q 12hrs |
| Halothane | Gaseous anaesthesia | Induction: 3% | Inhalant | stat |
| Maintenance: 0.5-1.5% | Inhalant | as needed | ||
| Haemoglobin (polymerised bovine) | Blood replacement | 10-30 ml/kg | IV | stat |
| Heparin | Aortic thromboembolism, thrombophlebitis | Initial dose: 100-200 IU/kg | IV | then |
| Maintenance dose: 50-100 IU/kg | SQ | q 6 - 8hrs | ||
| Aortic thromboembolism | Induction 1000 IU/kg | IV | then | |
| Maintenance: 50 IU/kg | SQ | q 8hrs | ||
| Pancreatitis | 50-1000 IU/kg | SQ | q 8 - 12hrs | |
| DIC | 75-100 IU/kg | IV, SQ | q 6hrs | |
| Lipoprotein lipase provocation test | 100 IU/kg | IV | test lipids before and 15 mins after heparin | |
| Heparin, LMW | see Dalteparin | |||
| Hetacillin | Susceptible infections | 10-20 mg/kg | PO | q 8 - 12hrs not associated with feeding |
| Hetastarch (Hydroxyethyl starch) | Plasma volume expander | 10-20 ml/kg | IV | as needed |
| Human gammaglobulin | Immune-mediated disease | 0.5-1.5 g/kg | IV | q 12hrs (infusion) |
| Hycodan (Hydrocodone) | Antitussive | 0.22 mg/kg | PO | q 12hrs |
| Hyaluronate sodium | Synovitis | 3-5 mg/cat | intra-articular | q 7days |
| Hydralazine | Vasodilator: heart failure | 0.5 mg/kg, titrate up to 0.5-0.8 mg/kg (up to 10mg/cat) | PO | q 12hrs |
| Hydrochlorothiazide | Hypertension | 0.5-2.0 mg/kg | PO | q 12 - 24hrs |
| Nephrogenic diabetes insipidus | 0.5-5.0 mg/kg | PO | q 12hrs | |
| Hypoglycaemia | 2-4 mg/kg | PO | q 12hrs | |
| Calcium oxalate uroliths | 2 mg/kg | PO | q 12hrs | |
| Hydrocortisone | Replacement therapy | 0.5-1.0 mg/kg | PO | q 24hrs |
| Anti-inflammatory | 2.5-5.0 mg/kg | PO | q 12hrs | |
| Hydrocortisone aurate | Hypoadrenocorticism | 0.1-0.2 mg/kg | IM | q 8 - 12hrs |
| Immune-mediated haemolytic anaemia | 2-4 mg/kg | IM | q 12 - 24hrs | |
| Hydrocortisone sodium succinate | Shock | 8-150 mg/kg | IV | stat |
| Hydrogen peroxide (3%) | Emetic | 5-10 ml/cat | PO | stat |
| Hydroxyurea | Primary polycythemiapolycythemia | 25-30 mg/kg | PO | q 3days |
| Chronic granulocytic leukaemia | 0.5 g/m2 | PO | q 12hrs for 4-6 weeks, then halve dosage | |
| Hydroxyzine | Antihistamine | 5-10 mg/cat | PO | q 12hrs |
| Hypertonic saline | Shock | 2-6 ml/kg | rapid IV infusion | stat |
| Idarubicin HCl | Antiviral | 2.0 mg/kg | PO | q 24hrs for 2 days, then repeat q21 days |
| Idoxuridine | Ocular herpes viral infection | 0.1% solution: 1 drop | topically | q 4 - 6hrs |
| 0.5% ointment | topically | q 1hr | ||
| Imidopril | Congestive heart failure and Chronic renal disease | 150 mg syrup | PO | 0.5cc q 24hrs |
| Imipenem-cilastin (Broad-spectrum 'Gorilla-cillin') | Susceptible infections | 2-10 mg/kg | IM or slow IV | q 6 - 8hrs |
| Imipramine | Behavioural modification, urinary incontinence | 2.5-5.0 mg/cat | PO | q 12hrs |
| Insulin, glargine | Diabetes mellitus | 0.25-5.0 U/kg | SQ | q 12hrs, adjust as needed |
| Insulin, lente | Diabetes mellitus | 0.5 U/kg | SQ | q 12 - 24hrs |
| Insulin, NHP | Diabetes mellitus | 1-3 U/cat | SQ | q 12 - 24hrs |
| Insulin, PZI | Diabetes mellitus | 1-3 U/cat | SQ | q 12 - 24hrs |
| Insulin, regular | Diabetes mellitus | 1-2 U/cat | SQ | q 6 - 8hrs |
| Insulin, ultralente | Diabetes mellitus | 1-3 U/cat | SQ | q 12 - 24hrs |
| Ipakitine | Chronic renal disease | 1 g/cat | PO | q 12 hrs |
| Interferon α</font>2, human recombinant</font> | Immunostimulant in non-neoplastic feline leukemia | 15-30 U/cat | IM, SQ, PO | q 24hrs on alternate weeks |
| FeLV appetite stimulant | 1 U/cat | PO | q 24hrs | |
| FIP (dry) | 30 U/cat | PO | q 24hrs on alternate weeks | |
| FIP(wet) | 2000 U/cat | IM | q 24hrs | |
| Conjunctivitis | 10 U/cat | PO | q 24hrs | |
| Interferon-α2b, human recombinant | Immunostimulation | 15-30 U/cat | PO, SQ, IM | q 24hrs for 7 days |
| Interferon-Ω, feline recombinant | Immunostimulation | 1 million U/kg | SQ | q 48hrs, reducing to once weekly if responding |
| Iodine | Hyperthyroidism | 50-100 mg/cat | PO | q 24hrs |
| Iodide sodium, potassium 20% solution | Hyperthyroidism, Sporotrichosis spp | 20 mg/kg | PO | q 12 - 24hrs |
| Iopamidol | Myelography | 0.25 ml/kg | intrathecal | stat |
| Ipecac syrup | Emetic | 2-6 ml/cat | PO | stat |
| Ipodate | Hyperthyroidism (short term) | 15 mg/kg | PO | q 12hrs |
| Iron dextran | Anaemia | 50 mg/cat | IM | at 18 days of age |
| Isoflurane | Gaseous anaesthesia |
Induction: 5% Maintenance: 1.5-2.5% | Inhalation | stat |
| Isometheptene | Urethral antispasmodic | 0.25-0.5 ml/cat | IM | q 12hrs |
| 0.5 tab/cat | PO | q 12hrs | ||
| Isoniazid | Mycobacterium spp infections | 10-20 mg/kg | PO | q 24hrs |
| Isopropamide (anticholinergic) | Sinus bradycardia, SA or AV block | 0.2-0.4 mg/kg | PO | q 8 - 12hrs |
| Antidiarrhoeal, GIT hypermotility | 0.2-1.0 mg/kg | PO | q 12hrs | |
| Isoproterenol - isoprenaline (ß2- agonist) | Bradycardia, AV block, cardiac arrest | 0.04-0.08 µg/kg | IV infusion | as needed |
| Feline asthma | 0.44 mg/kg | PO | q 6 - 12hrs | |
| 0.5ml of 1:200 dilution | Inhalant | q 4hrs x 3 | ||
| Isosorbide dinitrate | Vasodilator, osmotic diuretic, [megaoesophagus.htm megaoesophagus] | 2.5-5.0mg/cat | PO | q 12hrs |
| Isotretinoin (Vitamin D analogue) | Acne | 5 mg/kg | PO | q 24hrs |
| Itraconazole | Fungal infections or generalised dermatomycosis | 5-10 mg/kg | PO | q 12 - 24hrs |
| Ivermectin | Heartworm disease prophylaxis | 24 µg/kg | PO | once monthly |
| Microfilaricidal | 50 µg/kg | PO | stat | |
| Endoparasiticidal | 200-400 µg/kg | IM, SQ, PO | weekly | |
| Cheyletiella spp, Notoedres spp | 200-400 µg/kg | SQ | stat | |
| Jenotone (Aminopropazine fumarate) | Urinary tract obstruction | 2 mg/kg | IM, SQ | q 12hrs |
| Kanamycin | Susceptible infections | 10-15 mg/kg | IV, IM, SQ | q 12hrs |
| GI tract bacterial overgrowth | 10-12 mg/kg | PO | q 8 - 12hrs | |
| Kaolin / pectin | GI tract protectant | 1-2 ml/kg | PO | q 2 - 6hrs |
| Ketamine (NMDA-receptor antagonist) | Anaesthesia (with xylazine) | 7-11 mg/kg (0.2-0.5ml) | IV | stat |
| Sedation (with diazepam) | 5.5-10.0 mg/kg (0.3-0.5ml) | IV | stat | |
| Ketoconazole | Systemic and cutaneous mycoses, Sporotrichosis spp | 5.0-10.0 mg/kg | PO | q 12 - 24hrs |
| Fungal infections, CNS mycoses | 15-20 mg/kg | PO | q 12hrs | |
| Ketoprofen (NSAID) | Anti-inflammatory | 0.5-1.0 mg/kg | PO, IM, SQ | q 24hrs |
| L-asparaginase (Chemotherapeutic agent) | Lymphosarcoma | 10,000 U/m2 | IV | weekly as part of a protocol |
| Lactated Ringer's solution | Rehydration | 40-50 ml/kg | IV | q 24hrs |
| Lactilol | Stool softener, hepatic encephalopathy | 250 ml/cat | PO | q 12hrs |
| Lactoferrin | FIV stomatitis | 40 mg/kg | Topical | q 24hrs |
| Lactulose | Hepatic encephalopathy | 2.5-5.0 ml/cat | PO | q 8hrs |
| 5-10 ml diluted in water (1:3) | Rectal | stat | ||
| Stool softener | 1 ml/cat | PO | q 8hrs to effect | |
| Lamisil (Terbinafine) | Fungal infections | 5-10 mg/kg | PO | q 24hrs for 2-4 weeks |
| Lenperone | Opioid preanesthetic | 0.22-0.88 mg/kg | IM, IV | stat |
| Leucovorin | Methotrexate toxicity | 3 mg/m2 | IM | within 3hrs of poisoning |
| Pyrimethamine antidote | 1 mg/kg | PO | stat | |
| Levallorphan (1st generation opiate antagonist) | Opioid toxicity/overdose | 0.02-0.20 mg/kg | IV | as needed |
| Levamisole | Heartworm disease | 10 mg/kg | PO | q 24hrs for 7 days |
| Heartworm disease, Filaroides, Lungworm | 25 mg/kg | PO | q 48hrs for 14 days | |
| Hookworms | 10 mg/kg | PO | q 24hrs for 2 days | |
| Immune stimulant | 4.4 mg/kg | PO | stat | |
| Levarterenol (Norepinephrine) | Positive ionotrope | 0.05-0.3 μg/kg | IV | q1 min |
| Levetiracetam ( Nootropic agent) | Seizures (add-on) | 15-20 mg/kg | PO | q 8 - 12hrs |
| Cognitive disorders | 15-20 mg/kg | PO | q 8 - 12hrs | |
| Levodopa (L-DOPA) | Hepatic encephalopathy | 6.8 mg/kg initially, then 1.4mg/kg | PO | q 6hrs |
| Levothyroxine (Synthetic T4) | Hypothyroidism | 10-30 μg/kg | PO | q 12hrs |
| Lidocaine (Xylocaine) | Ventricular arrhythmias | 0.25-1.0 mg/kg | IV | then |
| 10-40 μg/kg | IV | per min | ||
| Epidural | 4.4 mg/kg | epidural | stat | |
| Lime sulphur | Sarcoptic mange | 1:40 dilution | Topically | weekly for 6 weeks |
| Lime water | Alkaline gastric lavage | 5 ml/kg | PO | stat |
| Lincomycin | Susceptible infections | 11-33 mg/kg | PO, IV, IM | q 12 - 24hrs |
| Liothyronine (T3) | Hypothyroidism | 4.4 μg/kg | PO | q 8 - 12hrs |
| Lisinopril (ACE inhibitor) | Afterload reduction (vasodilator) | 0.25-5.0 mg/kg | PO | q 24hrs |
| Lobaplatin | Chemotherapy | 35 mg/m2 | IV | q 3hrs |
| Lomustine | Chemotherapy | 100-150 mg/m2 | PO | q 6 weeks (subsequent dose based on WBC) |
| Loperimide | Antidiarrhoeal | 0.1-0.3 mg/kg | PO | q 12 -2 4hrs |
| Lufenuron | Immunomodulator | 15-30 mg/kg | PO | q 24hrs with meal for 30 days |
| Flea control | 10 mg/kg | SQ | ||
| Antifungal [fungal%20diseases.htm (ringworm)] | 80 mg/kg | PO | repeat in 2 weeks | |
| Lufenuron / milbemycin | Heartworm disease prevention | 1 tablet for appropriate size | PO | monthly |
| Luteinizing hormone (LH) | Stimulate ovulation | 50 IU/cat | IM | after mating |
| L-lysine | Eosinophilic keratitis / Herpes rhinitis | 250-500 mg | PO | q 12 - 24hrs |
| Lysine-8-vasopressin | Central diabetes insipidus | 1-2 sprays | conjunctival | q 8 - 24hrs |
| Magnesium citrate | Laxative | 2-4 ml/kg | PO | stat |
| Magnesium hydroxide | Antacid | 5-10 ml/cat | PO | q 8 - 24hrs |
| Cathartic | 2-6 ml/cat | PO | q 24hrs | |
| Magnesium salts | Laxative | 2-5 g/cat | PO | q 24hrs |
| Magnesium sulphate (25%) | Hypomagnesemia | 5-15 mmol/cat | IM, IV | over 1 - 2 hrs |
| Mannitol 5-20% | Oliguric renal failure | 0.25-1.0 g/kg | IV over 15-60 min | q 4 - 6hrs to maintain urine flow |
| Glaucoma | 1-3 mg/kg | IV over 15-20 min | ||
| CNS oedema | 1.5 mg/kg | IV | stat | |
| Marbofloxacin (Zenequin) | Susceptible infections | 2.75-5.5 mg/kg | PO | q 24hrs |
| Maropitant (Cerenia ™ ) | Anti-emetic | 1.0 mg/kg | SQ/PO | q 24 hrs for 4 days, then rest 2 days |
| Mebendazole | Parasites | 22 mg/kg | PO | q 24hrs for 3 days |
| Meclizine (antihistamine) | Motion sickness, nausea | 12.5 mg/cat | PO | q 24hrs, 1 hr before driving |
| Medetomidine | Chemical restraint, sedation, analgesia, muscle relaxant | 50-150 μg/kg | SQ, IM | stat |
| Medium chain triglycerides | Chylothorax | 14 ml/cat with each meal | PO | as needed |
| Primary lymphangiectasia, Exocrine pancreatic insufficiency | 14 ml/cat | PO | q 6 - 8hrs | |
| Medroxyprogesterone acetate (MPA-50; 50mg/ml) | Prevent abortion | 1-2 mg/kg | IM | once weekly, stop 7-10 days before parturition |
| Urine marking, anxiety, intraspecies aggression, skin conditions | 10-20 mg/kg | SQ | as needed, up to 3 injections per year | |
| Skin conditions | 50-100 mg/cat | SQ, IM | q 3 - 6mths as needed | |
| Behavioural disorders | 100 mg/cat | IM | then | |
| 30-50 mg/cat | monthly | |||
| Megestrol acetate (Ovarid) (WARNING: carcinogenic, diabetogenic) | Gingivitis | 2.5-5.0 mg/cat | PO | q 24hrs for 10 days, then q48hrs for 5 treatments, then as needed |
| Urethritis | 2.5-5.0mg/cat | PO | q 24 - 48hrs for 14-21 days until remission, then 1-2 weeks | |
| Miliary dermatitis, eosinophilic granuloma complex | 2.5 mg/cat | PO | q 24hrs for 10 days then q48hrs | |
| Eosinophilic granuloma complex | 0.5 mg/kg/day | PO | for 7-14 days | |
| Eosinophilic ulcers | 5-10 mg/cat | PO | q 48hrs for 10 - 14 treatments then q 2nd week | |
| Oestrus prevention | 2.5-5.0 mg/cat | PO | q 7 days | |
| Asthma | 5 mg/cat | PO | q 24hrs for 4 months, then weekly for 4 weeks | |
| Chemical contraception | 5.0 mg/cat | PO | q 24hrs for 3 days, then weekly as needed | |
| Meglumine antimonate | Leishmania spp | 5-30 ml/cat | IV, IM, IP | q 48 - 72hrs |
| Meloxicam (COX-2 inhibitor) | Antiinflammatory | 0.1 mg/kg | PO | q 24hrs as needed |
| Melphalan (nitrogen mustard alkylating agent) | Multiple myeloma | 0.05 mg/kg | PO | q 24hrs for 2 weeks, then q48hrs |
| Ovarian carcinoma, multiple myeloma, lymphoreticular neoplasms, osteosarcoma, mammary or pulmonary neoplasms, FIP, Feline leukemia | 2 mg/m2 | PO | q 48hrs | |
| Mepiridine (pethidine) | Sedation | 1-5 mg/kg | IM | q 2 - 4hrs |
| Mepivacaine | Local analgesia | 1-5 ml of 2% solution | SQ | as needed |
| 6-Mercaptopurine | Chronic myelocytic leukaemia, Lymphoma | 2 mg/kg | PO | q 24hrs |
| Meropenem | Susceptible infections | 20 mg/kg | IV | q 8hrs |
| Meningitis | 40 mg/kg | IV | q 8hrs | |
| Mesna | Haemorrhagic cystitis associated with cyclophosphamide | 40% of cyclophosphamide dose | PO, IV, IM, SQ | q 3hrs x 6 at time of cyclophosphamide treatment, follow with repeat dose (24 hr infusion) |
| Metamucil | Laxative | 2-4 g/cat | in moistened food | q 12 - 24hrs |
| http://en.wikipedia.org/wiki/Metaproterenol Metaproterenol sulphate] (ß2-agonist) | Bronchodilation | 0.325-0.65 mg/kg | PO | q 4 - 6hrs |
| Metaraminol (α1-agonist) | Vascular support during shock | 0.01-0.1 mg/kg | IV slowly | stat |
| http://en.wikipedia.org/wiki/Metformin Metformin] | Hyperglycaemia (non-insulin-dependant diabetes mellitus) | 2 mg/kg | PO | q 12hrs |
| Methazolamide | Glaucoma | 1-2 mg/kg | PO | q 12hrs |
| Methenamine hippurate | Urinary antiseptic | 250 mg/cat | PO | q 12hrs (use with extreme caution) |
| Methicillin (ß-lactam antibiotic) | Susceptible infections | 20 mg/kg | IM, IV | q 6hrs |
| Methimazole | Hyperthyroidism | 5 mg/cat (induction) | PO | q 8hrs, followed by |
| 2.5-5.0 mg/cat | PO | q 8 - 12hrs | ||
| (DL) Methionine (essential AA) | Urinary acidifier | 0.2-1.5 g/cat (Adult cats only) | PO | q 24hrs |
| Methocarbamol (guaifenesin-analogue) | Muscle relaxation | 20-66 mg/kg | PO | q 8 - 12hrs |
| Relief of moderate conditions | 44 mg/kg | IV | ||
| Controlling effects of strychnine and tetanus | 55-220 mg/kg; give 1/2 dose rapidly until relaxation occurs and continue at 20-66 mg/kg (not to exceed 330 mg/kg/day) | IV | as needed | |
| Methohexital (thiopentone analogue) | Anaesthesia induction | 2.5% solution: 11 mg/kg | IV | stat |
| Methotrexate sodium | Chemotherapy | 2.5 mg/m2 | PO | q 24hrs or 2 - 3 x weekly, in a protocol on day 14 with 5 mg prednisolone PO q 12hrs |
| Carcinomas, sarcomas | 10-15 mg/m2 | PO | q 1 - 3 weeks | |
| Methoxamine (α1-agonist) | Vasopressor: cardiac arrest, shock | 200-250 μg/kg or 40-80 μg/kg | IM | stat |
| Methoxyflurane | Inhalation anaesthesia | Induction: 3%, Maintenance: 0.5-1.5% | Inhalation | stat |
| Methscopolamine bromide | Anti-emetic | 0.3-1.0 mg/kg | PO | q 8hrs (use cautiously) |
| Methylcellulose | Laxative | 1.0-1.5 g/cat | PO | as needed |
| Methylene blue 0.1% | Indicator dye | 3 mg / 250 ml 0.9% NaCl | IV over 30-40 min | |
| Antidote | 1-1.5 mg/kg | IV | stat | |
| Methylprednisolone | Antiinflammatory | 0.5-1.0 mg/kg | PO | q 12hrs |
| Methylprednisolone acetate | sinophilic ulcers, linear granulomas | 10-40 mg/cat | SQ, IM, intralesional | q 2 weeks x 2 - 6 treatments |
| Asthma | 1-2 mg/kg | IM | q 7 days | |
| Others | 5.5 mg/kg | SQ, IM | 1 - 24 weeks | |
| Methylprednisolone sodium succinate | Spinal trauma | 15-30 mg/kg | IV | q 2hrs, then q 6hrs for 2 days, then taper dose over 5 - 7 days |
| 4-Methylpyrazole | Antifreeze toxicity | 20 mg/kg | IV | stat |
| 15 mg/kg | IV | q 12hrs for 2 days, then | ||
| 5 mg/kg | IV | |||
| Methyltestosterone | Anabolic steroid | 1-2 mg/kg | PO | q 24hrs |
| Testosterone-responsive dermatoses | 1-2.5 mg/cat | PO | q 48hrs | |
| Metoclopramide | Gastric motility disorders, antiemetic | 0.2-0.5 mg/kg | PO, IM, SQ | q 8hrs |
| 1.0-2.0 mg/kg | IV | q 24hrs | ||
| Gastric reflux | 0.2-0.4 mg/kg | PO | q 8hrs, 30 mins before meals | |
| [[Dysautonomia|Feline dysautonomia] | 0.3 mg/kg | PO | q 8hrs | |
| Metoprolol (ß1-agonist) | Atrial fibrillation, [hypertrophiccardiomyopathy.htm hypertrophic cardiomyopathy] | 2-15 mg/cat | PO | q 8hrs |
| 12.5-25.0 mg/cat | PO | q 12hrs | ||
| Metronidazole | Colitis, Coccidiosis, Tritrichomoniasis, anaerobic infections | 10-25 mg/kg | PO | q 24hrs for 7 - 14 days |
| Gingivitis | 50mg/kg | PO | q 24hrs | |
| Mirtazepine | Antiemetic | 3mg/cat | PO | q 3days |
| Misoprostol (synthetic PGE1) | Mucosal protectant | 3-5 μg/kg | PO | q 12hrs as required |
| Miconazole | Fungal infections | 1-3 cm | topically | q 24hrs for 2 - 4 weeks |
| Midazolam (BZD analogue) | Preanaesthetic, sedation | 0.06-0.22 mg/kg | IM, IV | stat |
| Milbemycin oxime | Heartworm and intestinal worm prophylaxis | 0.5-2.0 mg/kg | PO | monthly |
| Milk thistle (silymarin) | Free radical scavenger | 50-250 mg/kg | PO | q 12hrs |
| Mineral oil | Laxative | 5-10 ml/cat | PO, per rectum | q 12hrs |
| Minocycline (tetracycline antibiotic) | Susceptible infections | 5-15 mg/kg | PO | q 12hrs |
| Mithramycin | Hypercalcemia, testicular cancer, malignancies | 0.25-0.50 μg/kg | IV | q 24hrs x 2 |
| Mitotane (o,p-DDD) | Pituitary-dependant [Cushings.htm hyperadrenocorticism] | 25 mg/kg | PO | q 7 days (maintenance) |
| 75-100 mg/kg/week PO | ||||
| Mitoxantrone | Anticancer chemotherapy | 6.0-6.5 mg/m2 | IV | q 3-4 weeks x 4 - 6 |
| Morphine sulphate | Antitussive, analgesic | 0.05-0.1 mg/kg | SQ, IM | q 4 - 6hrs |
| Mycobacterial cell wall extract | Immunostimulation | 1.5 ml | IV, deep IM | q 24hrs x 1 |
| Nadolol (ß1/2- antagonist) | Hypertension | 0.25-0.5 mg/kg | PO | q 12hrs |
| Nafcillin (ß-lactam antibiotic) | Resistant staphylococcal infections | 10 mg/kg | PO, IM | q 6hrs |
| Nalbuphine hydrochloride (synthetic opioid) | Analgesic | 0.75-1.5 mg/kg | IV | q 6 - 8hrs |
| Nalorphine | Opioid antagonist | 0.1 mg/kg | IV | stat |
| Naloxone HCl | stereotypic behaviour | 20 mg | SQ | |
| Shock | 2 mg/kg | IV | q 1hr | |
| Opioid antagonist | 0.01-0.04 mg/kg | IV | to effect, repeat as needed | |
| Naltrexone (Trexan) | Behavioural problems, lick granuloma | 2.2 mg/kg | PO | q 12 - 24hrs |
| Nandrolone decanoate | Anaemia | 10-50 mg/cat | IM | weekly |
| Natamycin | Ocular fungal infections | topically | q 3 - 8hrs | |
| N-acetylcysteine | see Acetylcysteine | |||
| Neodarbazine | Antiemetic | 4.5-9.0 mg/kg | PO | q 12hrs |
| Neomycin | Susceptible infections | 7 mg/kg | IM, IV, SC | q 24hrs (nephrotoxic) |
| Hepatic encephalopathy | 10-20 mg/kg | per rectum | q 6hrs | |
| Neostigmine | Diagnostic aid for [myasthenia%20gravis.htm myasthenia gravis] | 20 μg/kg with 0.04 mg/kg of atropine | IV | stat |
| 2 mg/kg/day | PO | q 24hrs, divided doses | ||
| Niacin (Niacinamide) | Hypertriglyceridemia | 50-100 mg/day | PO | q 24hrs |
| Vacor toxicosis | 500-1000 mg | IM | stat, then | |
| 200 mg | PO | q 24hrs for 2 weeks | ||
| Nikethamide | Antidote for CNS-depressant drugs | 7.8-31.2 mg/kg | IV, IM, SQ | stat, then as needed |
| Nitrofurantoin | Urinary tract infection | 2.5-4.0 mg/kg | PO | q 6 - 8hrs |
| Prophylactic dose | 4 mg/kg | PO | q 24hrs | |
| Nitroglycerin 2% ointment | Vasodilator for pre-load reduction | 1/8-1/4 inch (0.3-0.6cm) | cutaneously | q 6 - 8hrs |
| Nitroprusside (vasodilator) | Acute CHF | 0.5-10 µg/kg | IV | q 1 min |
| Norepinephrine bitartrate | Positive ionotrope | 0.05-0.3 µg/kg | IV | q 1 min |
| Nortriptyline (tricyclic antidepressant - noradrenaline reuptake inhibitor) | Behaviour disorders | 0.5-2.0 mg/kg | PO | q 12 - 24hrs |
| Novobiocin | Susceptible infections | 10 mg/kg | PO | q 8hrs |
| Nystatin | Susceptible infections | 100,000 IU | PO | q 8hrs |
| Ofloxacin (fluoroquinolone) | Susceptible infections | 2.5-10.0 mg/kg | PO | q 12hrs |
| Olsalazine sodium | Inflammatory bowel disease | 10-20mg/kg | PO | q 12 - 24hrs |
| Omega fatty acids | see Derm caps | |||
| Omeprazole (Losec) - proton pump inhibitor | Gastritis, gastric ulceration | 5 mg/cat | PO | q 24hrs |
| Ondansetron - 5-HT3 receptor antagonists | Antiemetic | 0.5-1.0 mg/kg | PO | q 24hrs |
| Orbifloxacin | Susceptible infections | 2.5-7.5 mg/kg | PO | q 24hrs |
| Ovarid | (see Megestrol acetate) | |||
| Oxacillin | Susceptible infections | 22-40 mg/kg | PO | q 8hrs |
| Oxazepam | Appetite stimulant | 2.0-2.5 mg/cat | PO | q 12hrs |
| Oxtriphylline | Bronchodilator | 6 mg/kg | PO | q 8 -12hrs |
| 10-15 mg/cat | PO | q 6 - 8hrs | ||
| Oxybutynin (anticholinergic) | Detrusor hyperspasticity | 0.5 mg/cat | PO | q 8 - 12hrs |
| Oxymetholone | Anabolic agent | 1 mg/kg | PO | q 12 - 24hrs |
| Oxymorphone | Preanaesthetic | 0.1-0.2 mg/kg | IM, IV | with ACP or atropine |
| Oxytetracycline | Susceptible infections | 55-82.5 mg/kg | PO | q 8hrs |
| Haemobartonella | 20-40 mg/kg | PO | q 8hrs for 3 weeks | |
| Oxytocin | Acute metritis | 0.5-1.0 IU/kg | IV, IM, SQ | q 2hrs for max of 3 doses |
| Paclitaxel (mitotic inhibitor) | Chemotherapy | 5 mg/kg | IV | pre-treat for anaphylaxis |
| Pancreatic enzymes | Exocrine pancreatic insufficiency | 1-2 tablets, 1-2 teaspoons | PO | 20 mins prior to food, bid |
| Pancuronium bromide | Paralytic agent for controlled anaesthesia | 0.044-0.11 mg/kg | IV | stat |
| Paregoric | Antidiarrhoeal | 0.05-0.06 mg/kg | PO | q 8 - 12hrs |
| Paromomycin (aminosidine) | Cryptosporidium spp | 125-165 mg/kg | PO | q 12hrs for 5 days |
| Paroxetine (SSRI) | Behaviour modification | 1.25-2.5 mg/cat | PO | q 24hrs |
| Parvaquone | Toxoplasmosis | 10-30 mg/kg | IM | q 24hrs |
| D- penicillamine | Progressive hepatitis | 10-15 mg/kg | PO | q 12hrs |
| Penicillin G | Susceptible infections | 20-30 mg/kg | PO | q 6 - 8hrs |
| Pentazocine | Analgesia | 2.2-3.3 mg/kg | IV, IM, SQ | q 4hrs |
| Pentobarbital | General anaesthesia | 25-30 mg/kg | IV | to effect |
| Status epilepticus | 5-15 mg/kg | IV | to effect | |
| Sedation | 2-4 mg/kg | PO | q 6hrs | |
| Pentosan polysuphate | Disease modifying agent, arthritis | 3 mg/kg | IM, SQ | q 7 days |
| Pentoxifylline (phosphodiesterase antagonist) | Dermatomyositis | 100 mg/cat | PO | q 8 - 12hrs |
| Autoimmune skin diseases | 10-15 mg/kg | PO | q 24hrs | |
| Periactin | Appetite stimulant | 1-4 mg/cat | PO | q 12 - 24hrs |
| Petrolatum, white | Laxative | 1-5 ml/cat | PO | q 24hrs |
| Phenamidine isethionate | Babesiosis | 7.5 mg/kg | IM, SQ | q 24hrs x 2 |
| Phenobarbital | Status epilepticus | 2-30 mg/kg | PO, IM, IV | q 12hrs |
| Phenoxybenzamine HCl (α-adrenergic antagonist) | Acute hypertension from Pheochromocytoma | 0.5 mg/kg | PO | q 12hrs |
| Detrusor areflexia | 2.5-10 mg/cat | PO | q 8 - 12hrs | |
| Relaxation of urinary sphincter | 0.5 mg/kg | IV | stat | |
| Endotoxemia | 2.5-10.0 mg/cat | PO | q 24hrs | |
| Phentolamine (α-adrenergic antagonist) | Hypertension from Phaeochromocytoma | 0.02-0.1 mg/kg | IV | stat |
| Phenylephrine (α-adrenergic agonist) | Vasopressor, decongestant, mydriatic | 0.15 mg/kg | IV | as needed |
| Phenylpropanolamine | Urethral sphincter incompetence | 1.5-2.0 mg/kg | PO | q 8hrs |
| Phenytoin | Seizures, ventricular arrhythmias | 2-3 mg/kg | PO | q 24hrs |
| Phosphate (K or Na) | Hypophosphatemia | 4.5 mg/dl serum phosphate | IV | over 6 hrs |
| Physostigmine (parasympathomimetic) | Myasthenia gravis, Glaucoma, magic-mushroom intoxication | 0.25-5.0 mg/cat | IM | q 12hrs |
| Physostigmine (0.5%) | Feline dysautonomia | apply 1/8 inch | topically | q 8hrs |
| Phytomenadione | See Vitamin K1 | |||
| Pilocarpine 1% ophthalmic | Dysautonomia, glaucoma | 1 drop | topically | q 6hrs |
| Piperacillin sodium | Susceptible infections | 25-50 mg/kg | IV, IM | q 8 - 12hrs |
| Piperacillin-tazobactum | Susceptible infections | 25-50 mg/kg | IV | q 6 - 8hrs |
| Piperazine | Helminths | 44-66 mg/kg | PO | repeat in 3 weeks |
| Piroxicam (NSAID, non-selective COX inhibitor) | Analgesia, anticancer | 0.3 mg/kg | PO | q 24 - 72hrs |
| http://en.wikipedia.org/wiki/Plicamycin Plicamycin] | Hypercalcemia, testicular cancer, malignancies | 0.25-0.50 µg/kg | IV | q 24hrs x 2 |
| Polyethylene glycol | Lubricant, intestinal cathartic | 25 ml/kg | PO | then repeat in 2-4 hrs before GI exam |
| Polyethylene glycol electrolyte solution | Electrolyte replacement | 25 ml/kg | PO | q 2 - 4hrs |
| Polysulfated glycosaminoglycans | Degenerative joint disease | 2-5 mg/kg | IM | q 3 - 5days |
| Potassium chloride | Potassium supplementation | 0.10-0.25 ml/kg | PO | q 8hrs |
| Hypokalemia | 0.5 mEq/kg | IV | not to exceed 0.5 mEq/kg/hr | |
| 1-3 mEq | PO. IV | q 24hrs | ||
| 10-40 mEq/500 ml of fluid, depending on serum potassium | IV, SQ | stat | ||
| Potassium citrate | [flutd.htm Calcium oxalate urolithiasis] | 50-75 mg/kg | PO | q 12hrs |
| Potassium gluconate | Hypokalemic polymyopathy | 5-8 mEq/cat | PO | q 12 - 24hrs |
| Potassium iodide | Sporotrichosis spp, pythiosis | 30-100 mg/cat | PO | q 24hrs for 10-14 days |
| Potassium permanganate (1:2000) | Strychnine toxicosis | 5 ml/kg in gastric lavage | PO | stat |
| Potassium phosphate | see Phosphate | |||
| Povidone-iodine | Burns | Apply light coating | Topically | q 12 - 24hrs |
| Pralidoxime chloride (2-PAM) | Organophosphate toxicosis | 20 mg/kg | IV, IM, SQ | q 12hrs |
| Praziquantel | Tapeworms | 5 mg/kg | PO | stat |
| Paragonimus spp | 25 mg/kg | PO | q 8 - 12hrs for 2 days | |
| Prazosin (α1-adrenergic antagonist) | After load reductions | 0.5-2.0 mg/cat | PO | q 8 - 12hrs |
| Urethral obstruction | 0.5-2.0 mg/cat (0.07mg/kg) | PO | q 8 - 12hrs | |
| Prednisolone | Eosinophilic ulcers, plasma cell gingivitis | 1-2 mg/kg | PO | q 24hrs (each evening) |
| Plasmacytic lymphocytic enteritis | 1-2 mg/kg | PO | q 12hrs, then taper dose weekly | |
| Urethritis, persistent hematuria | 2.5-5.0 mg/kg | PO | q 24 - 48hrs | |
| Anti-inflammatory | 2.2 mg/kg | PO | q 12 - 24hrs | |
| Hypoadrenocorticism | 1 mg/kg | PO | q 12hrs | |
| Chronic therapy | 2-4 mg/kg | PO | q 48hrs | |
| Immune-mediated skin diseases | 1.1-2.2 mg/kg | PO | q 12hrs until remission, then taper | |
| FIP | 4 mg/kg | PO | q 24hrs with cyclophosphamide | |
| Allergy | 1 mg/kg | PO, IM | q 12hrs | |
| Immunosuppression | 3 mg/kg | PO | q 12hrs | |
| Lymphosarcoma, myeloproliferative disorders | 1 mg/kg | PO | q 24hrs | |
| Multiple myeloma | 0.5 mg/kg | PO | q 24hrs | |
| Prednisolone acetate | Hypoadrenocorticism | 0.1-0.2 mg/kg | IM | q 12hrs |
| Prednisolone sodium phosphate | Shock | 15 mg/kg | IV | q 4 - 6hrs |
| Prednisolone sodium succinate | Allergic bronchitis, asthma | 15-30 mg/kg | IV, IM | to effective dose |
| Shock | 15-30 mg/kg | IV | q 4 - 6hrs | |
| CNS trauma | 15-30 mg/kg | IV | then taper to effective dose | |
| Prilium | Congestive heart failure and Chronic renal disease | 150 mg syrup | PO | 0.5ml q 24hrs |
| Primaquine phosphate | Feline babesiosis | 0.5 mg/kg | PO, IM | stat |
| Procainamide | Ventricular arrhythmias | 62.5 mg/cat | PO | q 6hrs |
| Prochlorperazine | Antiemetic | 0.1 mg/kg | IM | q 6hrs |
| 0.5 mg/kg | PO | q 6 - 8hrs | ||
| Promazine hydrochloride | Preanaesthetic | 2.2-6.6 mg/kg | IV | stat |
| Antiemetic | 1-2 mg/kg | IM, IV | q 4 - 6hrs | |
| Promethazine HCl | Antihistamine, antiemetic | 0.2-0.4 mg/kg | IV, IM, PO | q 6 - 8hrs |
| Propantheline bromide | Acute colitis, irritable bowel syndrome, antiemetic | 0.22-0.25 mg/kg | PO | q 8hrs up to 3 days |
| Detrusor hyperspasticity, urge incontinence | 0.2 mg/kg | PO | q 6 - 8hrs | |
| Propriomazine | Sedation | 1.1-4.4 mg/kg | IV, IM | q 12 - 24hrs |
| Propionibacterium acnes | Immunostimulation, [feline%20leukemia.htm FeLV associated disease], retrovirus infection | 15 μg/kg | IV | biweekly for 2 - 3 weeks |
| Propofol | General anaesthesia | Induction: 6-8 mg/kg | IV | stat |
| Induction: 2.5-4.0 mg/kg | IV | with premedication | ||
| Maintenance: 0.51 mg/kg | IV | q min | ||
| Propranolol (ß-adrenergic antagonist) | Ventricular hypertrophy, aortic stenosis | 0.4-1.2 mg/kg | PO | q 8 - 12hrs |
| Ventricular arrhythmias | 0.02-0.06 mg/kg | IV | over 2-3 min; q 8hrs | |
| 0.25-0.5 mg | IV | followed by | ||
| 2.5-5.0 mg | PO | q 8hrs | ||
| hypertrophic cardiomyopathy, valvular insufficiency | 2.5 mg/cat | PO | q 8 - 12hrs | |
| Hypertension | 2.5-5.0 mg/cat | PO | q 8 - 12hrs | |
| Tachyarrhythmias from endocrinopathies | 2.5-5.0 mg | PO | q 8 - 12hrs | |
| Propylthiouracil (PTU) | Hyperthyroidism | 10 mg/kg | PO | q 8hrs |
| 50 mg/cat | PO | q 8 - 12hrs | ||
| Prostaglandin F2 alpha | Pyometra, Cystic endometrial hyperplasia | 0.10-0.25 mg/kg | SQ | q 24hrs for 3-5 days |
| Abortion | 0.5-1.0 mg/kg; 40 days post-conception | SQ | 2 injections 24 hrs apart | |
| Protamine sulphate | Heparin antagonist | 1.0-1.5 mg for every 100 IU heparin | IV | stat |
| Pseudoephedrine | Nasal decongestant | 15-30 mg/cat | PO | q 8 - 12hrs |
| Urinary incontinence | 0.2-0.4 mg/kg | PO | q 8 - 12hrs | |
| Psyllium | Bulk laxative | 1-3 tsp | PO | q 8 - 12hrs |
| Pyrantel pamoate | Roundworm, hookworm | 10 mg/kg | PO | repeat in 2 weeks |
| Pyridostigmine bromide | Myasthenia gravis(acquired) | 1-5 mg | PO | stat |
| 0.25 mg/kg | PO | q 24hrs | ||
| Antidote (curariform) | 0.15-0.30 mg/kg | IM, IV | ||
| Pyrilamine maleate | Antihistamine | 12.5-25.0 mg/cat | PO | q 6hrs |
| Pyrimethamine | Malaria, Neosporosis | 0.25-1.0 mg/kg | PO | q 24hrs |
| Toxoplasma | 0.5-2.0 mg/kg | PO | q 12hrs for 14 - 28days | |
| Enteroepithelial cycle | 2 mg/kg | PO | q 24hrs for 14 - 28 days | |
| Quinacrine | Giardia spp, Coccidiosis | 11 mg/kg | PO | q 24hrs for 5 days |
| Ranitidine (Zantac) | H-2 receptor antagonist for use in gastritis, GI tract ulceration | 0.5 mg/kg | IV, PO, SQ | q 12hrs |
| Hypergastrinemia associated with chronic renal insufficiency | 3.5 mg/kg | PO | q 12hrs | |
| Retinol (Vit A) | Dermatological lesions | 625-800 IU/kg | PO | q 24hrs |
| Ribavirin | Susceptible viral infections | 11 mg/kg | PO, IM, IV | q 24hrs for 7 days |
| Riboflavin (Vit B12) | Bartonellosis (with doxycycline) | 5-10 mg/kg | PO | q 24hrs for 14days |
| Rifampin | Susceptible infections | 10-20 mg/kg | PO | q 24hrs |
| Ringer's solution | Maintenance solution | 40-50 ml/kg | IV, SC, IP | q 24hrs |
| Ronidazole (Ronivet) | Tritrichomoniasis | 30 mg/kg | PO | q 24hrs for 14 days |
| (warning: low therapeutic margin) | 20mg/kg | PO | q12hrs for 14 days | |
| Roxithromycin | Susceptible infections | 15 mg/kg | PO | q 24hrs |
| Rutin | Chylothorax, limb lymphedema | 50 mg/kg | PO | q 8hrs |
| Selegiline (Fitergol) | Cognitive disorders | 0.5 mg/kg | PO | q 24hrs |
| Hyperadrenocorticism | 1-2 mg/kg | PO | q 24hrs | |
| Selamectin | Parasiticide | 6 mg/kg | Topical | q 30days |
| Selenious acid, sodium selenite | Supplementation | 0.3 mg/kg | PO | stat |
| Selenium | Pancreatitis | 0.1 mg/kg | IV | stat |
| Senna | Constipation | 5 ml/cat | PO | q 24hrs |
| Silver nitrate solution (0.5%) | Burns | Saturate wet dressing | Topically | q 12hrs |
| Silver sulfadiazine | Burns | Apply light coating | Topically | q 12hrs |
| Sodium bicarbonate | Renal failure | 10-15 mg/kg | PO | q 8hrs |
| Toxicoses | 50 mg/kg | PO | q 8 - 12hrs | |
| Hyperkalemic crisis | 2-3 mEq | IV | over 30 mins | |
| Urine alkalisation | 0.65-5.85 g | PO | q 24hrs | |
| Sodium chloride | Hypoadrenocorticism | 1-5 g | PO | q 24hrs |
| Hyponatremia, acute renal failure | 1-4 g | PO | q 8hrs | |
| (0.9% soln) | 40-50 ml/kg | IV, SQ, IP | q 24hrs | |
| Sodium iodide, 20% soln | Sporotrichosis spp | 0.5 ml/5kg | PO | q 24hrs |
| Susceptible infections | 20 mg/kg | PO | q 24hrs for 4 - 6 wks | |
| Sodium phosphate | Hypercalcemia | Dilute 1-3 g with water (1:1) and give 10-20 ml | PO | q 8 - 24hrs until stools are soft |
| Hypercalcemia | 8-15 g/cat | PO | q 8hrs | |
| Sodium thiopental | Anaesthesia | 3-15 mg/kg | IV | to effect |
| [http:// Sorbitol] (70% soln) | Stool softener | 3 ml/kg | PO | stat |
| Sotalol (ß-adrenoceptor antagonist) | Ventricular arrhythmias | 1-2 mg/kg | PO | q 12hrs |
| Spectinomycin | Susceptible infections | 5-12 mg/kg | IM | q 12hrs |
| Spiramycin | Toxoplasmosis | 12.5-23 mg/cat | PO | q 24hrs |
| Spironolactone | Diuretic: heart failure | 2-4 mg/kg | PO | |
| Primary hyperaldosteronism | 1 mg/kg | PO | q 12hrs | |
| Hepatic insufficiency | 12.5 mg/cat | PO | q 24hrs | |
| Spironolactone / hydrochlorothiazide | Diuretic, antihypertensive agent | 1-2 mg/kg | PO | q 12-24hrs |
| Stanozolol | Anabolic agent, anaemia | 1-2 mg/cat | PO | q 12hrs |
| 10-25 mg/kg | PO | q 7days | ||
| Staphage lysate | Immune stimulant | 0.1-0.2 ml/cat | SQ | then |
| incremental doses to 1.0ml | SQ | 1 - 2 for a week, then | ||
| 0.5 ml | SQ | weekly for 10 - 12 weeks | ||
| Staphylococcal A | Immune stimulant | 20 μg/2.75kg | IP | q 3 - 5 days |
| Streptomycin, dihydro | Leptospirosis, endocarditis, tuberculosis, Yersinia pestis | 10 mg/kg | IM | q6hrs |
| Styrid caricide (styrylpyridium chloride plus diethylcarbamazine) | Antiparasiticide | 6.7mg/kg | PO | q 24hrs |
| Succinylcholine | Paralysis | 0.06-0.11 mg/kg | IV | stat |
| Sucralfate | Gastrointestinal ulceration | 250-500 mg/cat | PO | q 8 - 12hrs |
| Hemorrhagic pancreatitis, vomiting with renal failure | 40 mg/kg | PO | q 8hrs | |
| Sufentanil (opioid agonist) | Premedicant with ACP | 2 μg/kg (max dose 5 μg/kg) | IV | stat |
| Sulfadiazine | Nocardiosis | 220 mg/kg | PO | for 1 treatment, then |
| 50-110 mg/kg | PO | q 12hrs | ||
| Toxoplasmosis | 15-50 mg/kg (with pyrimethamine) | PO | q 24hrs, divided, for 14 days | |
| Sulfadiazine / trimethoprim | Susceptible infections | 30 mg/kg | PO, SQ | q 24hrs |
| Meningitis | 15 mg/kg | PO, IV | q 8 - 12hrs | |
| Nocardiosis | 30-60 mg/kg | PO, SQ | q 12hrs | |
| Sulfadimethoxine | Susceptible infections | 25-50 mg/kg | PO, IM, IV | q 12 - 24hrs for max of 21days |
| Coccidiosis | 55 mg/kg (loading), then 27.5 mg/kg | PO | q 24hrs | |
| Sulfaguanidine | Coccidiosis | 100-200 mg/kg | PO | q 8hrs |
| Sulfamethazine, sulfamerazine | Coccidiosis | 200 mg/kg (loading), then 50 mg/kg | PO | q12hrs |
| Sulfamethoxazole | Susceptible infections | 100 mg/kg (loading), then 50 mg/kg | PO | q 12hrs |
| Sulfamethoxazole / trimethoprim | Susceptible infections | 15 mg/kg | PO | q 12hrs |
| Sulfasalazine | Lymphocytic plasmacytic enteritis | 250 mg/cat | PO | q 8hrs for 3 days, then q 24hrs |
| Inflammatory bowel disease | 20-25 mg/kg | PO | q 12 -24hrs | |
| Susceptible bacterial infections | 20 mg/kg | PO | q 12hrs | |
| Sulfisoxazole | Urinary tract infections | 50 mg/kg | PO | q 8hrs |
| Sulfobromophthalein sodium | Hepatic function testing | 5 mg/kg | IV | collect serum 30 min after BSP injection |
| Suprofen ophthalmic | Allergic conjunctivitis | 1% | Topically | q 8 - 12hrs |
| Tamiflu | Viral disease | 2-4 mg/kg | PO | q 12hrs within 48hrs of infection |
| Taurine | Taurine deficiency, dilated cardiomyopathy | 250-500 mg/cat | PO | q 12hrs |
| Central retinal degeneration | 250 mg/cat | PO | q 12 - 24hrs | |
| Telazol (Zoletil - Tiletamine / zolazepam) | Restraint | 6.6 mg/kg | IM | stat |
| Anaesthesia | 11-15 mg/kg | IM | stat | |
| Temaril-P (Trimeprazine and prednisolone) | Allergy | 0.7-1.1 mg/kg | PO | q 12 - 24hrs |
| Terbinafine (Lamasil) | Fungal infections | 3-10 mg/kg | PO | q 24hrs for 3 - 4 wks |
| Terbutaline (ß2-adrenoceptor agonist) | Bronchodilator | 0.01 mg/kg | SQ, IM | q 4hrs |
| 1.25-2.5 mg/cat | PO | q 8hrs | ||
| Testosterone cypionate | Hormone replacement | 2.2 mg/kg | IM | q 2 - 3 days |
| Testosterone, methyl | Anabolic effects | 1-2 mg/kg; max 30 mg/day | PO | q 24hrs |
| Testosterone propionate | Feline symmetrical alopecia | 12.5 mg with oestrogen | IM | stat |
| Urinary incontinence | 5-10 mg | IM | stat | |
| 0.5-1.0 mg/kg | IM | q 2 - 3 days | ||
| Tetanus toxoid | Tetanus treatment | 0.2 ml (test dose), then give 100-500 units/kg | SQ | watch for anaphylaxis for 30 min |
| Tetracycline hydrochloride | Acute bronchitis | 10-25 mg/kg | PO | q 8 - 12krs |
| [[Rickettsia spp] | 15 mg/kg | PO | q 8hrs for 21 days | |
| Mycobacterium spp | 22 mg/kg | PO | q 8hrs | |
| Susceptible infections | 1-5 mg/kg | IV, IM | q 8 - 12hrs | |
| Theophylline | Bronchodilator | 4 mg/kg | PO, IM | q 8 - 12hrs |
| Theo-Dur (Sustained release) | Bronchodilator | 20-25 mg/kg | PO | q 24hrs, at night |
| Thiabendazole | Heartworm disease adulticide | 35 mg/kg | PO | q 12hrs for 20 days |
| Strongyloides | 125 mg/kg | PO | q 24hrs for 3 days | |
| Thiacetarsamide | Heartworm adulticide | 2.2 mg/kg | IV | q 12hrs for 2 days |
| Thiamine (Vit B12) | Thiamine deficiency | 1-2 mg/cat | IM | q 12hrs until regression of symptoms |
| 100-250 mg/kg | SQ | q 12hrs | ||
| Thiamylal sodium | Anaesthesia | 8.8-13.3 mg/kg | IV | after tranquilisation |
| Thioguanine | Lymphocytic and granulocytic leukaemia | 25 mg/m2 | PO | q 24hrs for 1-5 days, then 130 days |
| Thyroid | Hypothyroidism | 15-20 mg/kg/day | PO | q 24hrs |
| Thyrotropin (TSH) | Provocative testing | 1 IU/kg | IM | Collect baseline and post-TSH samples |
| Acanthosis nigrans, hypothyroidism | 1-2 IU | SQ | q 24hrs for 5 days | |
| L-Thyroxine (levothyroxine) | Hypothyroidism | 0.5 mg/m2 | PO | q 12hrs |
| 20-30 μg/kg | PO | q 24hrs | ||
| Ticarcillin | Susceptible infections | 33-50 mg/kg | IM, IV | q 6 - 8kg |
| 55-110 mg/kg | IM, Iv | q 4 - 6hrs | ||
| Ticarcillin/clavulanate | As above | |||
| Tiletamine / zolazepam | Minor procedure | 9.7-11.9 mg/kg | IM | stat |
| Castration | 10.6-12.5 mg/kg | IM | do not exceed 72mg/kg with repeat doses | |
| Spey | 14.3-15.8 mg/kg | IM | stat | |
| Tinidazole | Stomatitis | 15 mg/kg | PO | q 24hrs |
| Tiopronin | Cystine urinary calculi | 15-20 mg/kg | PO | q 12hrs |
| Tolazoline | Xylazine reversal | 2 mg/kg | IV | stat |
| Tolfenamic acid (Tolfedine) | Analgesia | 4 mg/kg | IM, SQ, PO | q 24 hrs up to 5 days, 3 out of 7 days for long term Rx |
| Toltrazuril (Baycox) | Coccidiosis | 5-20 mg/kg | PO | q 24hrs x 2-5 treatments |
| Toluene | Anthelmintic | 267 mg/kg | PO | repeat in 2-4 weeks |
| Tramadol | Opioid analgesia | 1-2 mg/kg | PO | q 8 - 12hrs |
| 12.5 mg/cat | PO | q12hrs | ||
| Tretinoin | [acne.htm Feline acne], nasal hyperkeratosis | 0.25-0.5 mg/kg | PO | q24hrs for 7 days |
| Triamcinolone | Gingivitis, pododermatitis | 2-4 mg | PO | q 24 - 48hrs |
| Hypokalemic polymyopathy | 0.5-1.0 mg/kg | PO | q 24hrs | |
| Antiinflammatory | 0.11-0.22 mg/kg | IM, SQ | stat | |
| Pannus, eosinophilic keratitis, episcleritis | 4 mg | Subconjunctival | stat | |
| Triamcinolone acetonide | Esophageal stricture | 1-2 mg/cat | submucosal | stat |
| Glucocorticoid effect | 0.1-0.2 mg/kg | IM, SQ | q 24hrs | |
| Triamterene | Diuretic | 1-2 mg/kg | PO | q 12hrs |
| Trientine hydrochloride | Chelating agent | 10-15 mg/kg | PO | q 12hrs |
| Triethylene thiophosphoramide | Bladder neoplasia | 30 mg/m2 | Intravesicular | q 3 - 4wks |
| Thiethylperazine | Antipsychotic | 0.13-0.2 mg/kg | IM | q 8 - 12hrs |
| Trifluoperazine | Antipsychotic | 0.03 mg/kg | IM | q 12hrs |
| Triflupromazine | Behaviour modification | 0.1-0.3 mg/kg | IM, PO | q 8 - 12hrs |
| Trifluridine ophthalmic | herpes infection | 0.1% soln, 1-2 drops | Topically | q 34 - 8hrs |
| Triiodothyronine (T3) | Hypothyroidism | 4.4 µg/kg | PO | q 8 - 12hrs |
| Trimethoprim/sulfadiazine | Susceptible infections | 15 mg/kg | PO, SQ, IV | q 8 - 12hrs |
| Tripelennamine | Antihistamine | 1 mg/kg | PO, IM | q 12hrs |
| Trypan blue | Feline babesiosis | 4 mg/kg | IV | stat |
| Tylosin | GI bacterial overgrowth | 6.6-11 mg/kg | IM | q 12 - 24hrs |
| Chronic colitis | 25 mg | PO | q 8hrs | |
| Urea | Osmotic | 300 mg | IV | stat |
| Urofollitropin | Hypogonadotropic anovulation | 2 mg/cat | IM | q 24hrs |
| Ursodeoxycholic acid (Ursodiol) | Chronic hepatitis | 5-15 mg/kg | PO | q 24hrs |
| Valproic acid | Epilepsy | 25-65 mg/kg | PO | with Phenobarbital |
| 10-105 mg/kg | PO | alone | ||
| Vanadium | Hyperglycaemia | 0.2 mg/kg | PO | q 24hrs |
| Vasopressin, aqueous | Central diabetes insipidus | 10 mU/cat | IV, IM | as needed |
| Vasopressin, tannate in oil | Central diabetes insipidus | 2.5-5.0 U/cat | IM | q 1- 7 days |
| Vecuronium bromide | Paralytic agent for controlled anaesthesia | 40 μg/kg | IV | over 30 min |
| Verapamil (calcium channel blocker) | Supraventricular arrhythmias | 10-15 mg/kg | PO | q 24hrs, divided |
| Conversion of rapid supraventricular tachycardia | 1.1-4.4 mg/kg | PO | q 8 - 12hrs | |
| Vidarabine | Ocular herpesviral infection | 1/8 inch | Topically | q 6 - 8hrs |
| Vinblastine | Mast cell tumour, [lymphosarcoma.htm LSA] | 0.1-0.4 mg/kg | IV | q7-14 days |
| Vincristine | Thrombocytopenia | 0.01-0.025 mg/kg | IV | q 7-10 days |
| Lymphosarcoma | 0.5-1.0 mg/m2 | IV | once weekly | |
| Neoplasia | 0.5-0.75 mg/m2 | IV | q 7 - 14days | |
| Viokase | Exocrine pancreatic insufficiency | 325 mg | PO | with each meal |
| Vitamin A | Dietary supplement | 400 U/kg | PO | q 24hrs for 10d |
| Vitamin B1 | see Thiamine | |||
| Vitamin B2 | 5-10 mg/cat | PO | q 24hrs | |
| Vitamin B complex | Vitamin B deficiency | 0.5-1.0 ml | IV, IM, SQ | q 24hrs |
| Vitamin C | see Ascorbic acid | |||
| Vitamin D (dihydrotachysterol) | Hypocalcemia | 0.02 mg/kg | PO | Initially, then |
| 0.01 mg/kg | PO | q 24 - 48hrs | ||
| Vitamin D2 (ergocalciferol) | Hypocalcemia | 4000-6000 U/kg | PO | q 24hrs, initially, then |
| 500-1000 U/kg | PO | q 24 - 48hrs | ||
| Vitamin D3 (calcitriol - 1-25, dihydroxy vitamin D3) | Hypocalcemia | 0.03-0.06 μg/kg | PO | q 24hrs |
| Chronic renal disease | 0.025 μg/kg | PO | q 24hrs | |
| Vitamin E | Vitamin E deficient myositis, [yellow%20fat%20disease.htm steatitis] | 10-20 IU/kg | PO | q 12hrs |
| autoimmune skin diseases | 400-600 IU/cat | PO | q 12hrs | |
| Vitamin K1 | Deficiency, hepatopathy | 1-3mg/kg | SQ, PO | q 12hrs for 4 - 6 weeks |
| 5mg/kg | PO | q 24hrs, divided doses | ||
| Warfarin | Aortic thromboembolism | 0.06-0.20 mg/kg | PO | q 24hrs. Maintain PTT at 2 - 2.5 times normal |
| Xylazine | Muscle relaxation | 1.1-2.2mg/kg | IM, SQ | stat |
| Emetic | 0.44mg/kg | IM | ||
| Zafirlukast | Leukotriene receptor antagonist | 0.15-0.2mg/kg | PO | q 12 - 24hrs |
| Zidovudine (AZT) | Antiviral | 5-20mg/kg | SQ, PO | q 8 - 12hrs |
| Zinc | Antioxidant | 2-3mg/kg | PO | q 24hrs |
| Zithromax (Azithromycin)] | Susceptible infections | 5mg/kg | PO | q 24 - 48hrs |
| Susceptible infections | 80mg stat | PO | weekly x 3 | |
